Trial Profile
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Acronyms JE-PIV
- Sponsors Intercell
- 05 Apr 2019 Results of a five year follow up study evaluating immune response after vaccination with the Japanese encephalitis vaccine published in the Vaccine
- 29 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2008 New trial record.